CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • ASCO 2022 Preview: The Latest Insights from the Front Lines of Cancer Immunotherapy

    CRI’s PRINCE Trial featured at ASCO22, along with sessions that highlight the latest clinical advances in checkpoint…

    June 2, 2022| Arthur N. Brodsky, PhD
  • Beyond the Prognosis and Treatment: Cancer Survivorship

    Cancer survivors have a diverse range of experiences with their diagnoses, treatment, and life after cancer.

    June 2, 2022| Max Mallet
  • Clinical Trials Drive Immunotherapy Progress. Are They for You?

    Immunotherapy clinical trials are critical endeavors that lead to breakthrough cancer treatments. 

    May 19, 2022| Max Mallet
  • Skin Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Skin Cancer Awareness month, discover new research, treatments, and progress for a future immune to skin…

    May 10, 2022| CRI Staff
  • How a Day of Golf and Beer Raised Money for Cancer Immunotherapy Research

    Birdies & Brews mixes beer and golf while raising funds for cancer immunotherapy research.

    May 6, 2022| Max Mallet
  • Bladder Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Bladder Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…

    May 4, 2022| CRI Staff
  • Brain Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Brain Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…

    May 3, 2022| CRI Staff
  • Melanoma Monday: 2022 Immunotherapy Research Updates

    This Melanoma Monday, discover new research, new treatments, and progress for a future immune to melanoma.

    May 2, 2022| CRI Staff
  • The Many Fates of T Cells with CRI Lloyd J. Old STAR Enrico Lugli, PhD

    CRI Lloyd J. Old STAR Enrico Lugli, PhD, is deciphering why some T cells have longevity and…

    April 18, 2022| Arthur N. Brodsky, PhD
Previous Page
1 … 17 18 19 20 21 … 91
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute